Clinical Trial Update: Evaluation of N1539 Following Abdominoplasty Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating N1539 for postoperative pain following abdominoplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• N1539

Snippet

Sponsor: Baudax Bio | Conditions: Pain, Post-operative | Phase 3 | Status: COMPLETED | Results posted: 2018-02-14